• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Education
  • Events
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs
  • Business Directory

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

Regulation relaxed for emergency naloxone supply during COVID-19

4th May 2020 by PIP editor Leave a Comment

 

It has been announced that there will be a widening of the availability of overdose reversal drug Naloxone while measures to tackle coronavirus remain in place.

 

The Lord Advocate has confirmed that for the duration of this crisis it would not be in the public interest to prosecute any individual working for a service registered with the Scottish Government who supplies naloxone in an emergency, to save a life.

 

Under existing UK legislation, supplies of naloxone can be held by non-drug treatment services for use in an emergency, but not for onward distribution. In the current crisis, it has been decided that this could present an obstacle to people receiving the treatment that they need.

 

Cabinet Secretary for Health and Sport Jeane Freeman commented:

 

“We’ve already announced a number of measures to ensure that treatment and support services are not disrupted, during this crisis.  As part of that, we have increased the availability of naloxone – a medication which reverses opiate overdose.

 

“Under existing UK legislation, supplies of naloxone can be held by non-drug treatment services for use in an emergency, but not for onward distribution.  In the current crisis that could present an obstacle to people receiving the treatment that they need.

 

“So that’s why the Lord Advocate has confirmed that for the duration of this crisis it would not be in the public interest to prosecute any individual working for a service registered with the Scottish Government who supplies naloxone in an emergency, to save a life.

 

“I hope that statement provides confidence and certainty to relevant professionals, as they carry out their important work.  And I hope it will further ensure that people can get the treatment they need when they need it.

 

Public Health Minister Joe FitzPatrick said:

 

“I welcome the Lord Advocate’s statement of prosecution policy in respect of the distribution of naloxone during the period of disruption caused by COVID-19. This will help to ensure that we can continue to support those affected by drug use and keep them safe.”

 

 

This circular is being shared under the Open Government Copyright licence.

 

 

 

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Related

Next article  Pledge to vaccinate 400k Scots a week by end of February

Filed Under: News Tagged With: Naloxone

Register for our upcoming webinar and live Q&A

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Categories

Follow Us

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter

PIP business directory

Letters to the editor

Letters to the editor

We need to talk about alcoholism in pharmacy

We don’t ask patients about their medicines as often as we should

Pharmacists must leave their comfort zone for the sector to thrive

Pharmacists should follow Canada and be able to change prescriptions

More letters to the editor here...

Blogs

💊 PIP live pharmacy blog

Winter stresses must not ‘destabilise’ general practice

What is it like to depend on medicine to treat endometriosis?

Opinion

Why is pharmacy not integral to government mass vaccination plans?

Pharmacy Covid-19 vaccination involvement is a ‘no-brainer’

The great patient medication returns debacle

CPD Challenges

💊 CPD Challenge: How well do you understand pulmonary embolisms?

💊 CPD Challenge: Prescribing and dispensing clozapine

💊 CPD Challenge: Oral anticoagulants – Dabigatran

More CPD challenges here...

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.